Larimar Therapeutics Reports Third Quarter 2025 Financial Results

Go back to Larimar Therapeutics Reports Third Quarter 2025 Financial Results
(NASDAQ: LRMR) Delayed: 2.96 -0.1 (3.27%)
Previous Close $3.06    52 Week High $ 
Open $3.11    52 Week Low $ 
Day High $3.11    P/E N/A 
Day Low $2.92    EPS $ 
Volume 835,020